SANUWAVE Health, Inc.'s Proposed Acquisition of Celularity's UltraMIST(R) and Exclusive Partnership Rights for Wound Care Biologic Products Is A Transformative Event; Increases Addressable Markets and Accelerates Revenue Growth In A $10 Billion Market
Miami Beach, Florida--(Newsfile Corp. - June 23, 2020) - When it comes to finding value within emerging technologies, staying focused on the companies that fill a niche market opportunity can deliver substantial rewards. In the regenerative medicine products space, SANUWAVE Health (OTCQB: SNWV) may be such a company, showing that its strong portfolio of non-invasive, wound-healing assets may present a best-in-class alternative to competing products and treatments. SANUWAVE recently announced...
2020-06-23 7:53 AM EDT
Here's How Akers Biosciences and Premas Biotech Plan To Knock Out COVID-19 Virus; Company Halfway Through Four Milestone Plan
New York, New York--(Newsfile Corp. - April 24, 2020) - Akers Biosciences (NasdaqCM: AKER) announced a licensing agreement with Premas Biotech to find an effective vaccine for COVID-19. Premas Biotech has over 125 employees and has delivered over 650 proteins and has completed over 240 separate projects for pharmaceutical companies. The company also has four candidates currently in clinical trials globally, and most notable, an oral insulin drug candidate which recently completed a Phase 2b...
2020-04-24 10:19 AM EDT
Envision Solar: Making a Case for Proactive Thinking Against a "Grid Pandemic" Situation
Miami Beach, Florida--(Newsfile Corp. - April 9, 2020) - There is no question that there is going to be a major move to electric vehicles as the technology continues to become more accessible to the public. And, this doesn't just include sedans - all terrestrial transportation will soon electrify, with maritime and large parts of airborne transportation already positioned to do the same. Electric ferries are becoming more common and hybrid ships are already here. However, one thing that...
2020-04-09 8:12 AM EDT
Iconic Brands' Bellissima Prosecco and Sparkling Wines Geared To Benefit From 450% Spike In Online Purchase Demand
New York, New York--(Newsfile Corp. - March 25, 2020) - The momentum at Iconic Brands (OTCQB: ICNB), Inc. is continuing. On Tuesday, the company reiterated that Bellissima Prosecco and Sparkling Wines are available for online orders and delivery through Splash Wines. Iconic Brands noted that Splash Wines can extend product delivery to most states and is offering free shipping through the use of the promo code: BELLISSIMA.The already established distribution agreement with Splash Wines follows...
2020-03-25 10:06 AM EDT
Soligenix Inc. Heat-Stabilization Platform Evaluating Use With COVID-19 Vaccine; Zacks Small-Cap Research Increases Valuation To $12.00 Per Share
New York, New York--(Newsfile Corp. - March 24, 2020) - Soligenix Inc. (NasdaqGS: SNGX), through its Public Health Solutions business segment, announced on Monday that the company is expanding its ongoing collaboration with the University of Hawai'i at Manoa to assess potential coronavirus vaccines, including COVID-19. More specifically, the study is evaluating the application of the company's heat-stabilization technology that has the potential to substantially alleviate the strains of...
2020-03-24 9:11 AM EDT
Soligenix, Inc. Impresses With Statistically Significant Topline Phase 3 Data From SGX301 FLASH Trial; Targets $250 Million CTCL Patient Market
New York, New York--(Newsfile Corp. - March 20, 2020) - Soligenix, on Thursday, announced positive topline data for its lead CTCL drug candidate, SGX301. The published data demonstrated statistically significant efficacy results in treating this challenging and often debilitating chronic cancer. Additionally, this potentially transformative milestone for Soligenix (NASDAQ: SNGX) positions the company to explore strategic partnership and commercialization opportunities to take advantage of...
2020-03-20 8:37 AM EDT
HealthLynked Brings COVID-19 Tracker Application To Market; Real-Time Tracking Data Offers Unique Monitoring Capability As Coronavirus Spreads Globally
New York, New York--(Newsfile Corp. - March 13, 2020) - HealthLynked made an important announcement on Monday that may have been overlooked by a raucous market. The release is worth another visit after HealthLynked (OTCQB: HLYK) said that is has developed technology to help track the spread of COVID-19 with its patient engagement platform. This may be the only known tracking system currently in the market and comes at a crucial time for the hopeful control of the COVID-19...
2020-03-13 8:08 AM EDT
Kuuhubb Is Well-Positioned For A Breakout Year in 2020; Female Gamers Market Hits One-Billion Users
New York, New York--(Newsfile Corp. - March 12, 2020) - Successful companies have at least one thing in common - they target substantial market opportunities that can deliver long-term rewards. Kuuhubb (TSXV: KUU) (OTC Pink: BCDMF), a lifestyle games and app company, embraces that philosophy. And, its path toward success is influenced by a primary motivator - to develop, create, and publish a bespoke mobile lifestyle for women.Since its beginnings in 2014, Kuuhubb has been on a mission to...
2020-03-12 7:40 AM EDT
Why Iconic Brand's Niche-Based Strategy May Be A Recipe For Success In The Celebrity-Inspired Alcohol Products Sector
New York, New York--(Newsfile Corp. - March 5, 2020) - The alcoholic beverage sector is a $1.7 trillion market that is a glaring case study for how a mixture of quality, combined with innovative and strategic marketing, can yield billions in sales. Placing even earned considerations on actual product quality aside, products like Grey Goose, Patron, Casamigos, and Jägermeister were once just modest proposals. But, through ingenious promotional campaigns that strategically positioned each...
2020-03-05 8:37 AM EST
Transportation and Logistics Systems, Inc. Is Accelerating Its Growth With Planned Acquisition of GRC Trucking, Inc.; Deal Expands Services In Trillion-Dollar E-Commerce Sector
New York, New York--(Newsfile Corp. - February 26, 2020) - The e-commerce market, led by industry giants Amazon, Apple, and Walmart, is expected to become a more than $4.8 trillion economy by the year 2021. And, while investors may have done well by recognizing the growth potential in those companies more than two decades ago, the opportunity to catch the derivative opportunities may still provide a lucrative return. Transportation and Logistics Systems, Inc (OTC Pink: TLSS) is one example...
2020-02-26 7:53 AM EST
Independent Case Study For Soligenix's CTCL Drug, SGX301, Drives Bullish Sentiment; Topline "FLASH" Trial Data Expected Q1 2020
Miami Beach, Florida--(Newsfile Corp. - February 20, 2020) - Soligenix may be nearing a transformative point in its history as data from its Phase 3 SGX301 (FLASH) trial to treat cutaneous T-cell lymphoma (CTCL) nears its release. The topline data from this late-stage study is expected in less than 40 days. And, if that release can validate data known from a recent case study performed by Dr. Brian Poligone, MD, Ph.D., then Soligenix (NASDAQ: SNGX) may earn the...
2020-02-20 8:49 AM EST
HealthLynked Corp Steps Up March Toward Profitability; Agrees To Acquire Cura Health Management and ACO Health Partners, LLC
New York, New York--(Newsfile Corp. - February 18, 2020) - HealthLynked Corp has made another acquisition. This time, they entered into a definitive agreement to acquire Cura Health Management, LLC (CHM), and its wholly-owned subsidiary, ACO Health Partners, LLC (AHP). The deal is expected to close in April of this year. Importantly, the transaction is expected to generate more than $2 million in additional revenue for HealthLynked (OTC: HLYK) and, at the same time, slash the company's cash...
2020-02-18 8:08 AM EST
Will PharmaCyte Biotech's Cell-in-a-Box(R) Technology Be The Game Changer To Effectively Treating Pancreatic Cancer?
New York, New York--(Newsfile Corp. - February 11, 2020) - Investors searching for emerging leaders in the cellular therapeutics sector may find interest in PharmaCyte Biotech, a company committed to its development of cancer and diabetes treatments that have the potential to revolutionize the current standard of care in treating chronic cancers and disease. Earlier this month, PharmaCyte (OTC: PMCB) announced that its proprietary live-cell technology platform for the potential treatment of...
2020-02-11 10:31 AM EST
PharmaCyte Biotech Exploits Potential Of Its Cell-in-a-Box(R) Technology; Targets Billion Dollar Cancer, Diabetes, and Medicinal Cannabinoid Markets
Miami Beach, Florida--(Newsfile Corp. - February 6, 2020) - For investors interested in finding undervalued opportunity, PharmaCyte Biotech may be a stock to watch as the company positions itself to potentially create enormous shareholder from its ongoing development of cellular therapies targeting cancer and diabetes. Just last week, PharmaCyte (OTCQB: PMCB) announced that its pancreatic cancer therapy utilizing proprietary live-cell technology passed critical FDA-required "release testing"...
2020-02-06 8:38 AM EST
Soligenix Stock Jumps 95% YTD Ahead of Topline Data Release For SGX301; Targeting $250 Million Unmet Market Opportunity To Treat CTCL
Miami Beach, Florida--(Newsfile Corp. - January 30, 2020) - Soligenix (NASDAQ: SNGX) stock continued its price surge with gains exceeding 95% since the first of the year*. Investors are eyeing the near-term release of topline data for its late-stage drug candidate, SGX301, targeting the treatment of CTCL. If the results are consistent with the expectations from interim analysis guidance, the drug can become the first approved front-line therapy for the disease and fill an unmet medical need....
2020-01-30 8:12 AM EST
Soligenix Shares Power Higher Ahead of SGX301 Phase 3 Data Release; Projected $200 Million Revenue Opportunity For CTCL Drug
Miami Beach, Florida--(Newsfile Corp. - January 16, 2020) - Soligenix (NASDAQ: SNGX), a late-stage pharmaceutical company working to improve the current standard of care for numerous rare diseases through the development and commercialization of novel treatments, is nearing the release of topline data after completing final enrollment for SGX301, a pivotal Phase 3 trial targeting the treatment of cutaneous T-cell lymphoma. A successful report may position the company for significant increases...
2020-01-16 8:42 AM EST
HealthLynked Is Driving The Revolution Toward Patient-Centered Medicine; HealthLynked Network Is Transforming The Way Healthcare Data Is Shared.
Miami Beach, Florida--(Newsfile Corp. - January 7, 2020) - Can you imagine a world where scheduling a doctor's appointment is as quick and easy as ordering an Uber? All your medical records flow easily from one doctor to another. A computer looks at your healthcare data and makes recommendations to optimize your health. With the HealthLynked Network (OTCQB: HLYK), that world is right at your fingertips. HealthLynked is singlehandedly changing the landscape of personal medical records transfer...
2020-01-07 7:37 AM EST